Insider · CIK 0001649867
Gerd Auffarth
Files at OTLK (Outlook Therapeutics, Inc.). First filing -, latest -.
In brief
Gerd Auffarth files SEC Form 4 as director at OTLK (Outlook Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Gerd Auffarth has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2025 | OTLK Outlook Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +286,734 | $0.00 | $0 | 286,734 | Oct 3, 2025 |
| Oct 3, 2025 | OTLK Outlook Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +58,648 | $0.00 | $0 | 58,648 | Oct 3, 2025 |
Questions about Gerd Auffarth
Answered from the filings on this page, as of the latest one.
Is Gerd Auffarth buying or selling?
Gerd Auffarth has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Gerd Auffarth's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gerd Auffarth has 0.
Where does Gerd Auffarth file Form 4?
Gerd Auffarth has filed Form 4 at OTLK (Outlook Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.